The referenced TTR composite endpoint is "Neuropathy Impairment Score of the Lower Limb" or NISLL. I cannot offer any further insight about it though
Opinions and comments may have been previously posted @BioDueDiligence, at www.biotechduediligence.com, or disseminated to Chimera Research Group subscribers.